Once it is submitted for review, we ask that the FDA be required to prioritize the approval and use of the bionic pancreas.
A bionic pancreas, designed to administer insulin and dispense glucagon to precisely increase blood sugar, will give type 1 diabetics the ability to function as if they had an actual pancreas. In 2013, 20 adults and 32 adolescents were involved in a trial using a bionic pancreas and showed dramatically improved average glucose levels and nearly eliminated hypoglycemia. The bionic pancreas has been in clinical studies at Massachusetts General Hospital since November 2013..
Making it available to type 1 diabetics will have a profound impact on their lives by helping them more effectively manage their condition.